Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2005 1
2007 1
2008 1
2012 3
2013 1
2014 6
2015 3
2016 2
2018 3
2019 3
2021 3
2022 5
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). Lalla RV, et al. Cancer. 2014 May 15;120(10):1453-61. doi: 10.1002/cncr.28592. Epub 2014 Feb 25. Cancer. 2014. PMID: 24615748 Free PMC article. Review.
Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis.
Barberio B, Segal JP, Quraishi MN, Black CJ, Savarino EV, Ford AC. Barberio B, et al. J Crohns Colitis. 2021 Jul 5;15(7):1184-1196. doi: 10.1093/ecco-jcc/jjab010. J Crohns Colitis. 2021. PMID: 33433562 Free article.
Combined therapy ranked first in trials where 50% of patients had left-sided/extensive disease, and topical mesalazine first in trials where 50% of patients had proctitis/proctosigmoiditis. High-dose [3.3 g/day] oral mesalazine ranked third in most analyses, with the most …
Combined therapy ranked first in trials where 50% of patients had left-sided/extensive disease, and topical mesalazine first in trials where …
Systematic review of therapies for refractory ulcerative proctitis.
Raja SS, Bryant RV, Costello SP, Barnett M, Schubert J, Rayner CK. Raja SS, et al. J Gastroenterol Hepatol. 2023 Apr;38(4):496-509. doi: 10.1111/jgh.16111. Epub 2023 Feb 6. J Gastroenterol Hepatol. 2023. PMID: 36644922 Review.
Patients with ulcerative proctitis have favorable long-term outcomes but are typically excluded from ulcerative colitis clinical trials. Refractory proctitis presents a management conundrum for gastroenterologists, and there remains a lack of clarity as to the best …
Patients with ulcerative proctitis have favorable long-term outcomes but are typically excluded from ulcerative colitis clinical tria …
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis.
Aruljothy A, Singh S, Narula N, Moran GW, Vuyyuru SK, Hogan M, Zayadi A, MacDonald JK, Caron B, Danese S, Peyrin Biroulet L, Ma C, Jairath V. Aruljothy A, et al. Aliment Pharmacol Ther. 2023 Oct;58(8):740-762. doi: 10.1111/apt.17666. Epub 2023 Aug 17. Aliment Pharmacol Ther. 2023. PMID: 37589498 Review.
BACKGROUND: Ulcerative proctitis (UP) is a common highly symptomatic form of ulcerative colitis that can be difficult to treat. ...
BACKGROUND: Ulcerative proctitis (UP) is a common highly symptomatic form of ulcerative colitis that can be difficult to treat. ...
Hyperbaric oxygen therapy for late radiation tissue injury.
Lin ZC, Bennett MH, Hawkins GC, Azzopardi CP, Feldmeier J, Smee R, Milross C. Lin ZC, et al. Cochrane Database Syst Rev. 2023 Aug 15;8(8):CD005005. doi: 10.1002/14651858.CD005005.pub5. Cochrane Database Syst Rev. 2023. PMID: 37585677 Review.
We added four new studies to this updated review and evidence for the treatment of radiation proctitis, radiation cystitis, and the prevention and treatment of osteoradionecrosis (ORN). ...
We added four new studies to this updated review and evidence for the treatment of radiation proctitis, radiation cystitis, and the p …
Drug therapies for ulcerative proctitis: systematic review and meta-analysis.
Lie MR, Kanis SL, Hansen BE, van der Woude CJ. Lie MR, et al. Inflamm Bowel Dis. 2014 Nov;20(11):2157-78. doi: 10.1097/MIB.0000000000000141. Inflamm Bowel Dis. 2014. PMID: 25072502 Review.
BACKGROUND: Patients with ulcerative colitis limited to the proctum are considered to have ulcerative proctitis (UP). In patients with more extensive ulcerative colitis, treatment occurs in a step-up fashion (5-ASA, corticosteroids, thiopurines, anti-TNF-alpha agents), a s …
BACKGROUND: Patients with ulcerative colitis limited to the proctum are considered to have ulcerative proctitis (UP). In patients wit …
Comparison of clinical manifestations in mpox patients living with HIV versus without HIV: A systematic review and meta-analysis.
Shin H, Shin H, Rahmati M, Koyanagi A, Jacob L, Smith L, Rhee SY, Kwon R, Kim MS, Kim S, Il Shin J, Min C, Cho W, Yon DK. Shin H, et al. J Med Virol. 2023 Apr;95(4):e28713. doi: 10.1002/jmv.28713. J Med Virol. 2023. PMID: 36991570
The odds ratio of the mpox outcomes with PLWH in comparison to patients without HIV was found to be significant for skin rash (1.24, 95% CI: 1.01-1.53), proctitis (2.03, 95% CI: 1.36-3.04), cough (0.57, 95% CI: 0.33-0.98), and diarrhea (3.85, 95% CI: 1.24-11.98). ...
The odds ratio of the mpox outcomes with PLWH in comparison to patients without HIV was found to be significant for skin rash (1.24, 95% CI: …
High dose rate brachytherapy in the management of anal cancer: A review.
Ali ZS, Solomon E, Mann P, Wong S, Chan KKW, Taggar AS. Ali ZS, et al. Radiother Oncol. 2022 Jun;171:43-52. doi: 10.1016/j.radonc.2022.03.019. Epub 2022 Apr 4. Radiother Oncol. 2022. PMID: 35381275 Review.
Mean disease free survival and overall survival were 77.3% (SD 6.6%, R: 66%-100%) and 82.5% (SD 13.7%, R: 70%-87.7%). Acute toxicity was mostly grade 1/2 dermatitis, proctitis or cystitis; G3 or higher toxicity was reported only in 4 patients in 2 studies (dermatitis n = 3 …
Mean disease free survival and overall survival were 77.3% (SD 6.6%, R: 66%-100%) and 82.5% (SD 13.7%, R: 70%-87.7%). Acute toxicity was mos …
Comparative efficacy of oral drugs for chronic radiation proctitis - a systematic review.
Liu L, Xiao N, Liang J. Liu L, et al. Syst Rev. 2023 Aug 22;12(1):146. doi: 10.1186/s13643-023-02294-2. Syst Rev. 2023. PMID: 37608385 Free PMC article.
BACKGROUND: Chronic radiation proctitis (CRP) is a long-term complication of pelvic radiotherapy that manifests as rectal bleeding, diarrhoea, fistula formation and obstruction. ...
BACKGROUND: Chronic radiation proctitis (CRP) is a long-term complication of pelvic radiotherapy that manifests as rectal bleeding, d …
Diagnosis and Management of Cuffitis: A Systematic Review.
Hembree AE, Scherl E. Hembree AE, et al. Dis Colon Rectum. 2022 Dec 1;65(S1):S85-S91. doi: 10.1097/DCR.0000000000002593. Epub 2022 Aug 25. Dis Colon Rectum. 2022. PMID: 36399769
This review found that the majority of the current literature fails to distinguish between classic cuffitis (a form of reminant ulcerative proctitis) and nonclassic cuffitis (resulting from other causes). Further work is needed to distinguish the unique risk factors and en …
This review found that the majority of the current literature fails to distinguish between classic cuffitis (a form of reminant ulcerative …
46 results